Danielle DeCourcey

Publications

1. Feasibility of a Serious Illness Communication Program for Pediatric Advance Care Planning. JAMA Netw Open. 2024 Jul 01; 7(7):e2424626. View Abstract
2. "At Least I Can Push this Morphine": PICU Nurses' Approaches to Suffering Among Dying Children. J Pain Symptom Manage. 2024 Aug; 68(2):132-141.e2. View Abstract
3. Reflecting Upon Our Stories: The Compendium of Narratives in Pediatric Critical Care Medicine. Pediatr Crit Care Med. 2024 Jul 01; 25(7):638-642. View Abstract
4. Economic Hardship at the End of Life for Families of Children With Complex Chronic Conditions. J Pain Symptom Manage. 2024 Apr; 67(4):e313-e319. View Abstract
5. The roles of preparation, location, and palliative care involvement in parent-perceived child suffering at the end of life. J Pediatr Nurs. 2023 Sep-Oct; 72:e166-e173. View Abstract
6. Parent Preferences and Experiences in Advance Care Planning in the Neonatal Intensive Care Unit. Am J Perinatol. 2024 05; 41(S 01):e1783-e1791. View Abstract
7. Advance Care Planning and Parent-Reported End-of-Life Outcomes in the Neonatal Intensive Care Unit. Am J Perinatol. 2024 05; 41(S 01):e1657-e1667. View Abstract
8. The Case for Advance Care Planning in the NICU. Pediatrics. 2022 12 01; 150(6). View Abstract
9. Relationships and Resources Supporting Children With Serious Illness and Their Parents. Hosp Pediatr. 2022 09 01; 12(9):832-842. View Abstract
10. An Automatic Pediatric Palliative Care Consultation for Children Supported on Extracorporeal Membrane Oxygenation: A Survey of Perceived Benefits and Barriers. J Palliat Med. 2022 06; 25(6):952-957. View Abstract
11. Bereaved Parent Perspectives on the Benefits and Burdens of Technology Assistance among Children with Complex Chronic Conditions. J Palliat Med. 2022 02; 25(2):250-258. View Abstract
12. Is this as good as it gets? Implications of an asymptotic mortality decline and approaching the nadir in pediatric intensive care. Eur J Pediatr. 2022 Feb; 181(2):479-487. View Abstract
13. Symptoms and Suffering at End of Life for Children With Complex Chronic Conditions. J Pain Symptom Manage. 2022 01; 63(1):88-97. View Abstract
14. Clinical Care Strategies That Support Parents of Children With Complex Chronic Conditions. Pediatr Crit Care Med. 2021 07 01; 22(7):595-602. View Abstract
15. The Words We Say. Pediatr Crit Care Med. 2021 05 01; 22(5):499-500. View Abstract
16. Factors Affecting Recruitment and Participation of Bereaved Parents in Research: A Brief Report. J Pain Symptom Manage. 2021 09; 62(3):e213-e217. View Abstract
17. Clinician Identified Barriers and Strategies for Advance Care Planning in Seriously Ill Pediatric Patients. J Pain Symptom Manage. 2021 09; 62(3):e100-e111. View Abstract
18. Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment. Pediatrics. 2021 02; 147(2). View Abstract
19. Weighing Distress and Benefit: Understanding the Research Participation Experiences of Bereaved Parents of Children With Complex Chronic Conditions. J Pain Symptom Manage. 2021 07; 62(1):39-47.e1. View Abstract
20. Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19. Pediatrics. 2021 02; 147(2). View Abstract
21. Development of a Stakeholder Driven Serious Illness Communication Program for Advance Care Planning in Children, Adolescents, and Young Adults with Serious Illness. J Pediatr. 2021 02; 229:247-258.e8. View Abstract
22. A Breather during the Time of Breathlessness. J Palliat Med. 2021 02; 24(2):289. View Abstract
23. "I Could Never Prepare for Something Like the Death of My Own Child": Parental Perspectives on Preparedness at End of Life for Children With Complex Chronic Conditions. J Pain Symptom Manage. 2020 12; 60(6):1154-1162.e1. View Abstract
24. Chronic Medication Use in Children Insured by Medicaid: A Multistate Retrospective Cohort Study. Pediatrics. 2019 04; 143(4). View Abstract
25. Association of Home Respiratory Equipment and Supply Use with Health Care Resource Utilization in Children. J Pediatr. 2019 04; 207:169-175.e2. View Abstract
26. Advance Care Planning and Parent-Reported End-of-Life Outcomes in Children, Adolescents, and Young Adults With Complex Chronic Conditions. Crit Care Med. 2019 01; 47(1):101-108. View Abstract
27. Patterns of Care at the End of Life for Children and Young Adults with Life-Threatening Complex Chronic Conditions. J Pediatr. 2018 02; 193:196-203.e2. View Abstract
28. It's Very Treatable. J Palliat Med. 2018 Apr; 21(4):574-575. View Abstract
29. Saying Goodbye. JAMA Pediatr. 2017 05 01; 171(5):417. View Abstract
30. Medication Reconciliation Failures in Children and Young Adults With Chronic Disease During Intensive and Intermediate Care. Pediatr Crit Care Med. 2017 Apr; 18(4):370-377. View Abstract
31. Suspected Cerebral Edema in Diabetic Ketoacidosis: Is There Still a Role for Head CT in Treatment Decisions? Pediatr Crit Care Med. 2017 Mar; 18(3):207-212. View Abstract
32. 526: DO INTERMEDIATE CARE UNITS ALTER INTENSIVE CARE UTILIZATION FOR CHILDREN WITH MEDICAL COMPLEXITY? Crit Care Med. 2016 Dec; 44(12 Suppl 1):208. View Abstract
33. 545: END-OF-LIFE CARE FOR CHILDREN WITH MEDICAL COMPLEXITY: DOES ADVANCE CARE PLANNING MATTER? Crit Care Med. 2016 Dec; 44(12 Suppl 1):213. View Abstract
34. The authors reply. Pediatr Crit Care Med. 2014 Mar; 15(3):285-6. View Abstract
35. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality*. Pediatr Crit Care Med. 2013 Sep; 14(7):694-700. View Abstract
36. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci. 2002 May 15; 22(10):4015-24. View Abstract
37. Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures. Neurosci Lett. 1999 Apr 16; 265(2):103-6. View Abstract
38. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem. 1998 Sep; 71(3):946-59. View Abstract
39. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett. 1997 Nov 07; 236(3):139-42. View Abstract
40. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5923-8. View Abstract
Show All Publications Show Fewer Publications